Correlation Between DiaMedica Therapeutics and Nuvation Bio
Can any of the company-specific risk be diversified away by investing in both DiaMedica Therapeutics and Nuvation Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DiaMedica Therapeutics and Nuvation Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DiaMedica Therapeutics and Nuvation Bio, you can compare the effects of market volatilities on DiaMedica Therapeutics and Nuvation Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DiaMedica Therapeutics with a short position of Nuvation Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of DiaMedica Therapeutics and Nuvation Bio.
Diversification Opportunities for DiaMedica Therapeutics and Nuvation Bio
-0.13 | Correlation Coefficient |
Good diversification
The 3 months correlation between DiaMedica and Nuvation is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and Nuvation Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvation Bio and DiaMedica Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DiaMedica Therapeutics are associated (or correlated) with Nuvation Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvation Bio has no effect on the direction of DiaMedica Therapeutics i.e., DiaMedica Therapeutics and Nuvation Bio go up and down completely randomly.
Pair Corralation between DiaMedica Therapeutics and Nuvation Bio
Given the investment horizon of 90 days DiaMedica Therapeutics is expected to generate 1.0 times more return on investment than Nuvation Bio. However, DiaMedica Therapeutics is 1.0 times less risky than Nuvation Bio. It trades about 0.08 of its potential returns per unit of risk. Nuvation Bio is currently generating about 0.04 per unit of risk. If you would invest 144.00 in DiaMedica Therapeutics on September 3, 2024 and sell it today you would earn a total of 422.00 from holding DiaMedica Therapeutics or generate 293.06% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
DiaMedica Therapeutics vs. Nuvation Bio
Performance |
| Timeline |
| DiaMedica Therapeutics |
| Nuvation Bio |
DiaMedica Therapeutics and Nuvation Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with DiaMedica Therapeutics and Nuvation Bio
The main advantage of trading using opposite DiaMedica Therapeutics and Nuvation Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DiaMedica Therapeutics position performs unexpectedly, Nuvation Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvation Bio will offset losses from the drop in Nuvation Bio's long position.| DiaMedica Therapeutics vs. Milestone Pharmaceuticals | DiaMedica Therapeutics vs. Seres Therapeutics | DiaMedica Therapeutics vs. Inhibikase Therapeutics | DiaMedica Therapeutics vs. Oncolytics Biotech |
| Nuvation Bio vs. DiaMedica Therapeutics | Nuvation Bio vs. Lyra Therapeutics | Nuvation Bio vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |